Atsena Secures FDA Fast Track Designation for ATSN-201 to Treat X-Linked Retinoschisis
With no approved treatments for XLRS, another promising gene therapy enters the fray. Atsena Therapeutics (North Carolina, USA) announced that…
With no approved treatments for XLRS, another promising gene therapy enters the fray. Atsena Therapeutics (North Carolina, USA) announced that…